Centene Co. (NYSE:CNC) is attracting increased interest from investment firms such as Atria Investments Inc, DekaBank Deutsche, Girozentrale, Comerica Bank and others who are growing their shareholdings. The firm reported
promising Q2 2024 earnings and has been given upgraded target estimates by analysts. However, their
Q2 earnings see a decline due to depreciating Medicaid membership. Despite this, Centene's stock continues to
outperform its competitors. It is also acknowledged for its diversity by
FAIR360 and has been named one of the 'Top 50 Companies for Diversity'. The Centene Foundation has set up
partnerships to increase access to affordable housing and health care services. The company's stock status is generally spotted as an opportunity for long-term value and growth, despite mixed reviews by hedge funds. Centene's declining stock and solid financials raise questions, hinting the market could be wrong about Centene Corporation. Centene's earnings and revenue for Q2 2024 saw an increase, beating previous expectations.
Centene Corporation CNC News Analytics from Tue, 24 Oct 2023 07:00:00 GMT to Sun, 04 Aug 2024 20:30:02 GMT -
Rating 6
- Innovation 3
- Information 7
- Rumor 1